Skip to content

To study effect of Triphaladhyam Ghritapana along with Carboxymethyl Cellulose (0.5 % ) eye drop in dryness of eyes.

A randomised controlled clinical trial to study the adjuvant effect of Triphaladhyam Ghritapana along with Carboxymethyl cellulose 0.5 percent eye drops administration on Shushkakshipaka with Special referance to Dry eye syndrome. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085067
Enrollment
70
Registered
2025-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H041- Other disorders of lacrimal gland

Interventions

None listed

Sponsors

Dr.Krishna Baban Gayake
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients having classical signs and symptoms like Shushkakshipaka like Gharsha (foreign body sensation), Rukshata (dryness of eyes), Daha (burning sensation), Kunita (photophobia). 2) Patients will be selected irrespective to gender and economical status. 3) Patients having Age between 16 years to 60 years.

Exclusion criteria

Exclusion criteria: 1) Patients having any conjunctival infections. 2) Systemic diseases like DM, HIV, HBsAg, neurotrophic deficiency. 3) Patients with Abhighataja Netra Roga. 4) Patients using contact lenses. 5) Patients having chalazion, trachoma,Refractive surgery like post of cataract.

Design outcomes

Primary

MeasureTime frame
Is Triphaladhyam Ghritapana along with Carboxymethylcellulose (0.5%) eye drops administration effective on Shushkakshipaka with Special Reference to Dry Eye SyndromeTimepoint: 15 days

Secondary

MeasureTime frame
Where trial group stands in Comparison with control group in reduction of sign and symptoms of shushkakshipakaTimepoint: 18 months

Countries

India

Contacts

Public ContactDr Krishna Baban Gayake

SMBT Ayurved College and Hospital

dr.tusharfirke@gmail.com9823388720

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026